Veterinary Medicine Advisory Committee; Notice of Meeting, 48931 [E6-13818]
Download as PDF
<![CDATA[
cprice-sewell on PROD1PC66 with NOTICES
Federal Register / Vol. 71, No. 162 / Tuesday, August 22, 2006 / Notices
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on September 19, 2006, from 8 a.m.
to 5:30 p.m.
Location: Hilton Washington DC
North/Gaithersburg, Salons C, D and E,
620 Perry Parkway, Gaithersburg, MD.
Contact Person: Ronald P. Jean,
Center for Devices and Radiological
Health (HFZ–410), Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 301–594–2036,
ext. 181, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512521. Please call the
Information Line for up-to-date
information on this meeting.
Agenda: The committee will discuss,
make recommendations and vote on a
premarket approval application for a
cervical disc prosthesis intended to treat
skeletally mature patients with
degenerative disc disease at one level
from C3–C7. Background information
for the topics, including the agenda and
questions for the committee, will be
available to the public 1 business day
before the meeting on the Internet at
https://www.fda.gov/cdrh/panel (click on
Upcoming CDRH Advisory Panel/
Committee Meetings).
Procedure: On September 19, 2006,
from 8:30 a.m. to 5:30 p.m., the meeting
will be open to the public. Interested
persons may present data, information,
or views, orally or in writing, on issues
pending before the committee. Written
submissions may be made to the contact
person on or before September 5, 2006.
Oral presentations from the public will
be scheduled for 30 minutes at the
beginning of the committee
deliberations and for 30 minutes near
the end of the deliberations. Time
allotted for each presentation may be
limited. Those desiring to make formal
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before September 5, 2006.
Closed Committee Deliberations: On
September 19, 2006, from 8 a.m. to 8:30
a.m., the meeting will be closed to
permit FDA to present to the committee
trade secret and/or confidential
commercial information (5 U.S.C.
552b(c)(4)) relating to pending issues
and applications.
Persons attending FDA’s advisory
committee meetings are advised that the
VerDate Aug<31>2005
15:34 Aug 21, 2006
Jkt 208001
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Shirley
Meeks, Conference Management Staff, at
301–827–7292, least 7 days in advance
of the meeting.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 14, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E6–13823 Filed 8–21–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Veterinary Medicine Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Veterinary
Medicine Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on September 25, 2006, from 8:30
a.m. to 5 p.m.
Location: DoubleTree Hotel, Plaza
Rooms II–III, 1750 Rockville Pike,
Rockville, MD.
Contact Person: Aleta Sindelar, Food
and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855, 240–276–
9004, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512548. Please call the
Information Line for up-to-date
information on this meeting.
Agenda: The committee will discuss
and make recommendations on the
microbial food safety of an antimicrobial
drug application currently under review
for use in food-producing animals in
accordance with the Center for
Veterinary Medicine’s guidance for
industry #152.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
48931
The background material for this
meeting will be posted on the Internet
no later than 1 business day before the
meeting at https://www.fda.gov/cvm/
default.html.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before September 13, 2006.
Oral presentations from the public will
be scheduled between approximately 1
p.m. and 2 p.m. Time allotted for each
presentation may be limited. Those
desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before
September 13, 2006.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Aleta
Sindelar at least 7 days in advance of
the meeting.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: August 16, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and
Planning.
[FR Doc. E6–13818 Filed 8–21–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Health Resources
and Services Administration (HRSA)
publishes abstracts of information
collection requests under review by the
Office of Management and Budget
(OMB), in compliance with the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35). To request a copy of
the clearance requests submitted to
E:\FR\FM\22AUN1.SGM
22AUN1
]]>Agencies
[Federal Register Volume 71, Number 162 (Tuesday, August 22, 2006)]
[Notices]
[Page 48931]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-13818]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Veterinary Medicine Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Veterinary Medicine Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on September 25, 2006, from
8:30 a.m. to 5 p.m.
Location: DoubleTree Hotel, Plaza Rooms II-III, 1750 Rockville
Pike, Rockville, MD.
Contact Person: Aleta Sindelar, Food and Drug Administration, 7519
Standish Pl., Rockville, MD 20855, 240-276-9004, or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), code 3014512548. Please call the Information Line
for up-to-date information on this meeting.
Agenda: The committee will discuss and make recommendations on the
microbial food safety of an antimicrobial drug application currently
under review for use in food-producing animals in accordance with the
Center for Veterinary Medicine's guidance for industry 152.
The background material for this meeting will be posted on the
Internet no later than 1 business day before the meeting at https://
www.fda.gov/cvm/default.html.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person on or before
September 13, 2006. Oral presentations from the public will be
scheduled between approximately 1 p.m. and 2 p.m. Time allotted for
each presentation may be limited. Those desiring to make formal oral
presentations should notify the contact person and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their presentation
on or before September 13, 2006.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Aleta Sindelar at
least 7 days in advance of the meeting.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: August 16, 2006.
Randall W. Lutter,
Associate Commissioner for Policy and Planning.
[FR Doc. E6-13818 Filed 8-21-06; 8:45 am]
BILLING CODE 4160-01-S
